Mia's Feed
Medical News & Research

Deep Sleep and Daytime Urinary Control Crucial in Managing Childhood Nocturnal Enuresis

Deep Sleep and Daytime Urinary Control Crucial in Managing Childhood Nocturnal Enuresis

Share this article

New research identifies deep sleep and daytime urinary control as key factors in the effective management of childhood nocturnal enuresis. Personalized strategies may improve treatment outcomes.

1 min read

Recent research highlights the important role of deep sleep patterns and daytime urinary regulation in effectively managing nocturnal enuresis, commonly known as bedwetting, in children. A study published in BMC Pediatrics analyzed 144 children aged 5 to 8 years with nocturnal enuresis, comparing those who responded well to treatment with those who did not.

The investigators found that children who experienced deep sleep and maintained good daytime urinary control were more likely to have successful treatment outcomes. Conversely, children with higher residual urine volumes, frequent bedwetting episodes, and poor medication adherence tended to have resistant forms of enuresis. Although higher urine volumes and poor adherence rates were observed in treatment-resistant cases, these factors did not reach statistical significance.

The study emphasizes the importance of personalized treatment approaches that consider individual clinical and behavioral factors, potentially enhancing therapeutic success in resistant cases. The researchers recommend further longitudinal studies to evaluate long-term treatment efficacy and to explore innovative interventions aimed at improving outcomes for children with this condition.

This study provides valuable insights into the multifaceted nature of childhood nocturnal enuresis and underscores the need for tailored management strategies to optimize patient outcomes.

Source: https://medicalxpress.com/news/2025-06-deep-daytime-key-nocturnal-enuresis.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Cancer Immunotherapy Brings New Hope for Advanced-Stage Patients

A groundbreaking Phase II clinical trial of PRL3-zumab reveals promising results in slowing disease progression in late-stage cancer patients unresponsive to traditional therapies, offering new hope for treatment-resistant cancers.

Growing Concerns as Family Doctors Approach Retirement Age Impacting Primary Care

A new study reveals that many family physicians in Ontario are approaching retirement age, risking primary care shortages. The aging workforce and patient complexity demand strategic solutions to ensure healthcare stability.